CHIP Landmark Ideas Series: Dr. Derrick Rossi

Speaker: Derrick Rossi, PhD, at Harvard Medical School

Date: September 19, 2022 at 4:00PM - 5:30PM

Talk details will be forthcoming.

Derrick Rossi received his B.Sc. and M.Sc. degrees from the University of Toronto, Canada in the 1990s, and his Ph.D. from the University of Helsinki, Finland in 2003. He trained as a post-doctoral fellow at Stanford University from 2003-2007. Dr. Rossi holds the position of Assistant Professor in the Stem Cell and Regenerative Biology Department at Harvard Medical School, and Harvard University. He is an investigator at the Immune Disease Institute (IDI), and the Program in Cellular and Molecular Medicine at Children’s Hospital Boston. He is also a principal faculty member of the Harvard Stem Cell Institute.

Dr. Rossi has received multiple awards including the Pathways to Independence (PI) award from the NIH, and a Robertson Investigator award from the New York Stem Cell Foundation. Time magazine cited Dr. Rossi’s discovery of modified-mRNA reprogramming as one of the top ten medical breakthroughs of 2010. Time magazine also named Dr. Rossi as one of “People Who Mattered” in 2010, and as one of the 100 Most Influential People (Time 100) in 2011.


Publications

Chen KY, Borglund EM, Postema EC, Dunn AG, Bourgeois FT. Reporting of clinical trial safety results in ClinicalTrials.gov for FDA-approved drugs: A cross-sectional analysis. Clinical trials (London, England) 2022.

Le Naour J, Sztupinszki Z, Carbonnier V, Casiraghi O, Marty V, Galluzzi L, Szallasi Z, Kroemer G, Vacchelli E. A loss-of-function polymorphism in compromises therapeutic outcome in head and neck carcinoma patients. Oncoimmunology 2022.

Klann JG, Strasser ZH, Hutch MR, Kennedy CJ, Marwaha JS, Morris M, Samayamuthu MJ, Pfaff AC, Estiri H, South AM, Weber GM, Yuan W, Avillach P, Wagholikar KB, Luo Y, Omenn GS, Visweswaran S, Holmes JH, Xia Z, Brat GA, Murphy SN. Distinguishing Admissions Specifically for COVID-19 from Incidental SARS-CoV-2 Admissions: A National Retrospective EHR Study. Journal of medical Internet research 2022.